Lysophosphatidic acid: friend or foe of the ovarian surface epithelium.
Park
Darren J
DJ
National Products and Cancer Biology Program, Cancer Research Center of Hawaii, USA.
Martyn
Kendra D
KD
Warn-Cramer
Bonnie J
BJ
D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D018031:Connexin 43 / Q000378:metabolism / Q000502:physiology*; D015536:Down-Regulation; D004848:Epithelium / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008246:Lysophospholipids / Q000032:analysis / Q000378:metabolism*; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000401:mortality / Q000473:pathology* / Q000503:physiopathology; D011379:Prognosis; D012680:Sensitivity and Specificity; D016019:Survival Analysis; D014407:Tumor Cells, Cultured
D014408:Biomarkers, Tumor; D018031:Connexin 43; D008246:Lysophospholipids; C032881:lysophosphatidic acid